Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

FDC vs PANACEA BIOTECH - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    FDC PANACEA BIOTECH FDC/
PANACEA BIOTECH
 
P/E (TTM) x 23.9 -60.9 - View Chart
P/BV x 3.5 0.9 396.0% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 FDC   PANACEA BIOTECH
EQUITY SHARE DATA
    FDC
Mar-23
PANACEA BIOTECH
Mar-23
FDC/
PANACEA BIOTECH
5-Yr Chart
Click to enlarge
High Rs318191 166.1%   
Low Rs229107 213.9%   
Sales per share (Unadj.) Rs107.575.1 143.2%  
Earnings per share (Unadj.) Rs11.7-5.5 -212.1%  
Cash flow per share (Unadj.) Rs14.00.9 1,597.8%  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs119.5137.7 86.7%  
Shares outstanding (eoy) m165.9161.25 270.9%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.52.0 128.0%   
Avg P/E ratio x23.4-27.1 -86.4%  
P/CF ratio (eoy) x19.5170.0 11.5%  
Price / Book Value ratio x2.31.1 211.2%  
Dividend payout %00-   
Avg Mkt Cap Rs m45,3689,142 496.3%   
No. of employees `000NANA-   
Total wages/salary Rs m3,9091,265 309.0%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m17,8384,599 387.8%  
Other income Rs m512517 99.2%   
Total revenues Rs m18,3505,116 358.7%   
Gross profit Rs m2,49647 5,308.2%  
Depreciation Rs m389391 99.5%   
Interest Rs m4144 92.1%   
Profit before tax Rs m2,578128 2,013.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m640466 137.4%   
Profit after tax Rs m1,938-337 -574.4%  
Gross profit margin %14.01.0 1,368.7%  
Effective tax rate %24.8363.5 6.8%   
Net profit margin %10.9-7.3 -148.1%  
BALANCE SHEET DATA
Current assets Rs m14,4315,623 256.6%   
Current liabilities Rs m7,2963,297 221.3%   
Net working cap to sales %40.050.6 79.1%  
Current ratio x2.01.7 116.0%  
Inventory Days Days26559 451.2%  
Debtors Days Days25148 526.3%  
Net fixed assets Rs m17,3477,028 246.8%   
Share capital Rs m16661 270.9%   
"Free" reserves Rs m19,6558,375 234.7%   
Net worth Rs m19,8208,436 235.0%   
Long term debt Rs m6202 2.8%   
Total assets Rs m31,79612,712 250.1%  
Interest coverage x64.13.9 1,649.0%   
Debt to equity ratio x00 1.2%  
Sales to assets ratio x0.60.4 155.0%   
Return on assets %6.2-2.3 -270.0%  
Return on equity %9.8-4.0 -244.5%  
Return on capital %13.22.0 661.7%  
Exports to sales %043.3 0.0%   
Imports to sales %8.524.4 34.6%   
Exports (fob) Rs mNA1,992 0.0%   
Imports (cif) Rs m1,5091,124 134.3%   
Fx inflow Rs m3,2591,992 163.6%   
Fx outflow Rs m1,5091,191 126.7%   
Net fx Rs m1,749801 218.3%   
CASH FLOW
From Operations Rs m1,549-4,225 -36.7%  
From Investments Rs m1114,303 2.6%  
From Financial Activity Rs m-1,800-184 979.4%  
Net Cashflow Rs m-138-105 131.8%  

Share Holding

Indian Promoters % 69.7 73.6 94.7%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 10.2 1.0 1,072.6%  
FIIs % 2.4 0.3 934.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 30.3 26.4 114.9%  
Shareholders   55,341 47,091 117.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare FDC With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on FDC vs Panacea Biotech

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

FDC vs Panacea Biotech Share Price Performance

Period FDC Panacea Biotech S&P BSE HEALTHCARE
1-Day 1.06% -1.74% 1.18%
1-Month -4.50% -20.01% -0.75%
1-Year 69.82% 11.75% 61.82%
3-Year CAGR 14.77% -12.26% 18.16%
5-Year CAGR 20.71% -9.98% 19.79%

* Compound Annual Growth Rate

Here are more details on the FDC share price and the Panacea Biotech share price.

Moving on to shareholding structures...

The promoters of FDC hold a 69.7% stake in the company. In case of Panacea Biotech the stake stands at 73.6%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of FDC and the shareholding pattern of Panacea Biotech.

Finally, a word on dividends...

In the most recent financial year, FDC paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of 0.0%.

Panacea Biotech paid Rs 0.0, and its dividend payout ratio stood at -0.0%.

You may visit here to review the dividend history of FDC, and the dividend history of Panacea Biotech.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.